Is bedaquiline available in tablet form?
Bedaquiline (Bedaquiline) is an antibiotic used to treat drug-resistant tuberculosis and is a new type of anti-tuberculosis drug. This medication is available as a tablet and is usually given orally to patients. Bedaquiline tablets are designed to improve patient compliance while facilitating dose adjustments in clinical applications. Bedaquilinetabletscontain fumaric acidBedaquiline, an oral diarylquinoline antimycobacterial drug. Each bedaquiline 20 mg tablet contains 20 mg of bedaquiline (equivalent to 24.18 mg of Bedaquiline fumarate). Each bedaquiline tablet100 mg tablet contains 100 mg of bedaquiline (equivalent to 120.89 mg of Bedaquiline fumarate).
Bedaquiline has a unique mechanism. It inhibits the ATP synthase of Mycobacterium tuberculosis, thereby preventing the energy production of the bacteria, ultimately leading to the death of the bacteria. This targeting effect allows bedaquiline to show good efficacy in the fight against multidrug-resistant tuberculosis (MDR-TB). Due to its oral dosage form, patients can conveniently take it at home without having to frequently travel to the hospital, which to a certain extent improves the accessibility and convenience of treatment.
In clinical use, the dosage and usage period of bedaquiline are usually determined by doctors based on the patient's condition. In general, the recommended starting dose for adult patients is 400 mg daily for two weeks, then moving to a maintenance dose three times weekly for up to 24 weeks. Such dosing schedules are designed to maximize the drug's efficacy while reducing the occurrence of side effects.
The use of bedaquiline may cause some adverse reactions, including but not limited to electrocardiogram changes, liver function abnormalities, etc. Therefore, when using this drug, doctors usually recommend that patients undergo regular electrocardiograms and liver function tests so that potential problems can be detected and dealt with promptly. At the same time, patients also need to be informed of possible adverse reactions so that they can be reported to their doctors in a timely manner.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)